SAREPTA THERAPEUTICS

Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.

SAREPTA THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Genetics Health Care Therapeutics

Founded:

1980-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.sarepta.com

Total Employee:

501+

Status:

Active

Contact:

5417543545

Email Addresses:

[email protected]

Total Funding:

1.38 B USD

Technology used in webpage:

SPF Domain Not Resolving Amazon Microsoft Azure DNS Amazon Virginia Region DMARC Mimecast ASP.NET 2.0 Symantec.cloud EasyDNS

Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

corvidia-logo

Corvidia

Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.

horizon-pharma-logo

Horizon Pharma

Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system

Current Employees Featured

douglas-s-ingram_image

Douglas S Ingram
Douglas S Ingram CEO & President @ Sarepta Therapeutics
CEO & President
2017-07-01

sandy-mahatme_image

Sandy Mahatme
Sandy Mahatme Chief Financial Officer, Chief Business Officer @ Sarepta Therapeutics
Chief Financial Officer, Chief Business Officer
2012-11-01

jayant-aphale_image

Jayant Aphale
Jayant Aphale Senior Vice President of Technical Operations @ Sarepta Therapeutics
Senior Vice President of Technical Operations

alex-lagadinos_image

Alex Lagadinos
Alex Lagadinos Associate Director, Corporate Development @ Sarepta Therapeutics
Associate Director, Corporate Development
2020-02-01

not_available_image

James Summerton
James Summerton Founder @ Sarepta Therapeutics
Founder

not_available_image

Kathy Behrens Wilsey
Kathy Behrens Wilsey Director @ Sarepta Therapeutics
Director
2009-03-01

gary-charbonneau_image

Gary Charbonneau
Gary Charbonneau SVP, GM , Head of Research & Early Development @ Sarepta Therapeutics
SVP, GM , Head of Research & Early Development
2021-02-01

william-bill-f-ciambrone_image

William (Bill) F. Ciambrone
William (Bill) F. Ciambrone Executive Vice President, Technical Operations @ Sarepta Therapeutics
Executive Vice President, Technical Operations
2019-11-01

gilmore-oneill_image

Gilmore O&s;Neill
Gilmore O'Neill Executive Vice President, R&D & Chief Medical Officer @ Sarepta Therapeutics
Executive Vice President, R&D & Chief Medical Officer

Founder

not_available_image

James Summerton

marwan-fawaz_image

Marwan Fawaz

Stock Details

Company's stock symbol is NASDAQ:SRPT

Acquisitions List

Date	Company	Article	Price
2019-02-27	Myonexus Therapeutics	Myonexus Therapeutics acquired by Sarepta Therapeutics	165 M USD
2014-07-07	Eisai	Eisai acquired by Sarepta Therapeutics	25 M USD
2008-03-12	Ercole Biotech	Ercole Biotech acquired by Sarepta Therapeutics	N/A

Investors List

roche-financial_image

Investments List

Date	Company	Article	Money raised
2021-03-16	StrideBio	Sarepta Therapeutics investment in Series B - StrideBio	81.5 M USD
2020-10-22	AavantiBio	Sarepta Therapeutics investment in Series A - AavantiBio	107 M USD
2018-08-09	Lacerta Therapeutics	Sarepta Therapeutics investment in Venture Round - Lacerta Therapeutics	30 M USD
2018-05-08	Myonexus Therapeutics	Sarepta Therapeutics investment in Corporate Round - Myonexus Therapeutics	60 M USD

Official Site Inspections

http://www.sarepta.com Semrush global rank: 1.15 M Semrush visits lastest month: 27.55 K

Host Informations
Whois Informations

Loading ...